High Intensity Dysphagia Therapy for Stroke
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to find the best way to help people regain their ability to swallow after a stroke. It tests a high-intensity therapy designed to improve swallowing (dysphagia) in stroke patients. The trial seeks individuals who have recently experienced an ischemic stroke (a type of stroke caused by blocked blood flow to the brain) and are having trouble swallowing. Participants should be able to follow simple instructions related to swallowing tasks. As an unphased trial, this study offers participants the chance to contribute to innovative research that could significantly enhance recovery outcomes for future stroke patients.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this protocol is safe for stroke recovery?
Research has shown that high-intensity therapy for dysphagia, or trouble swallowing, can help stroke patients improve their swallowing. This treatment focuses on helping patients regain this ability.
Regarding safety, studies have not reported significant negative effects from this therapy. It is generally well-tolerated, which is important because the therapy often includes exercises to strengthen swallowing muscles.
While specific risks are not fully detailed, the absence of major side effects in past studies suggests that the therapy is likely safe for most people. Those considering joining a clinical trial for this treatment should consult their healthcare provider for advice based on their specific health needs.12345Why are researchers excited about this trial?
Researchers are excited about high intensity dysphagia therapy because it offers a more aggressive rehabilitation approach compared to standard speech and swallowing therapy for stroke patients. Unlike traditional methods that may involve less frequent or intense sessions, this therapy focuses on high intensity exercises aimed at rapidly improving swallowing function. This could potentially lead to quicker recovery and better outcomes for those with acute dysphagia following a stroke, providing a significant improvement in patient quality of life.
What evidence suggests that this protocol is effective for dysphagia recovery after a stroke?
Research has shown that intensive therapy can help people who have trouble swallowing after a stroke. One study found that focused care after a stroke improved swallowing within a year. This trial will evaluate high-intensity dysphagia therapy for participants with acute dysphagia during their stay in an inpatient rehab facility. Another review highlighted that recovery from swallowing difficulties improves significantly over time with proper treatment. Overall, promising evidence suggests that high-intensity therapy can benefit stroke patients with swallowing issues.24678
Who Is on the Research Team?
Alba M Azola, MD
Principal Investigator
Johns Hopkins University
Are You a Good Fit for This Trial?
This trial is for adults aged 18-99 who have had an ischemic stroke and are experiencing acute swallowing difficulties (dysphagia) as a result. Participants must be able to follow simple instructions for swallowing therapy. It's not suitable for those under 18 or over 100, with other types of strokes, previous dysphagia, or advanced progressive neurological diseases.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive high intensity dysphagia therapy with daily sessions including swallowing exercises and device-assisted training
Follow-up
Participants are monitored for safety and effectiveness after treatment with a follow-up phone call
What Are the Treatments Tested in This Trial?
Interventions
- High Intensity Dysphagia Rehab
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor